New York, NY -- (SBWIRE) -- 02/19/2013 -- Entest Biomedical Inc. (OTC Pink: ENTB) stock is at $0.01, up 38.36 percent from its previous close of $0.01. The stock shows bullish trend as it made the up move with trading volume of 56.315 million shares, in contrast to the average daily trading volume of 905k shares. Its bullish trend is further confirmed by its MACD chart. The stock may go as high as $0.02 in its coming trading sessions. Its second resistance level is at $0.03.
Entest Biomedical is based out of California and it develops immunotherapeutic therapies. The company specializes in developing therapies for the veterinary market.
Find out where ENTB could be headed by getting the trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=ENTB
Office Depot Inc. (NYSE: ODP) opened at $5.06 and oscillated in the range of $4.98 and $6.09 in the latest trading session. It is currently at $5.06, up 10.24 percent from its previous close of $4.59. Office Depot shows bullish trend and the stock’s first resistance level is at $5.25. Upon breaching this level, the stock may touch $5.38. On the downside, it may slip to $5.01.
Office Depot traded 47.876 million shares in comparison to its usual trading volume of 5.126 million shares. The company is said to be in talks with Office Max for a possible merger.
Get the latest news and the daily report on ODP here:
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetreport.net/disclaimer-2/
WALL STREET REPORT